Libri di Brian Rous
Biografia e opere di Brian Rous
TNM Classificazione dei tumori maligni
editore: Raffaello Cortina Editore
pagine: 304
La nona edizione della Classificazione TNM dei tumori maligni fornisce i più recenti standard internazionalmente riconosciuti per descrivere e classificare la stadiazione dei tumori. Questa autorevole guida tascabile – pubblicata con il patrocinio dell’Unione Internazionale per il Controllo del Cancro – contiene le classificazioni aggiornate per i diversi organi, indispensabili agli oncologi e agli altri specialisti che si occupano dei pazienti neoplastici per una corretta stadiazione, definizione prognostica e pianificazione terapeutica.Completamente rivista alla luce delle più recenti evidenze cliniche, l’edizione introduce aggiornamenti sostanziali per numerose sedi tumorali – tra cui rinofaringe, orofaringe HPVcorrelato, polmone, timo, mesotelioma, appendice, canale anale, cervice, vulva e prostata – e propone sezioni rinnovate dedicate all’Essential TNM e alla stadiazione dei tumori pediatrici. Presenta inoltre nuove classificazioni per medulloblastoma, linfomi cutanei, carcinoma paratiroideo e tumori della midollare surrenalica e dei paragangli extra-surrenalici, oltre a una revisione dei principali fattori prognostici.
TNM Classification of Malignant Tumours
a cura di
Brian O'Sullivan
,
James D. Brierley
Meredith Giuliani
Elizabeth Van Eycken
Brian Rous
e altri
editore: John Wiley & Sons Inc
pagine: 272
The essential reference on cancer stage returns as a fully revised edition
Describing cancer stage is one of the most important elements of oncological practice. Clinical research and clinical care depend on an accurate assessment of cancer stage and prognostic factors. The TNM Classification of Malignant Tumours serves as the globally recognised standard reference for describing cancer stage and assessing treatment results. Now fully updated to reflect the results of the latest clinical research, it is indispensable for all clinicians, cancer registrars and researchers who work with malignant tumours.
Readers of the ninth edition of TNM Classification of Malignant Tumours will find:
Updates in many tumour sites including, nasopharynx, HPV associated oropharynx, lung, thymus, mesothelioma, appendix, anal canal, cervix, vulva and prostate carcinoma;
Revised and updated sections on Essential TNM and paediatric cancer staging;
New classifications for medulloblastoma, cutaneous lymphoma, parathyroid carcinoma, adrenal medulla and extra-adrenal paraganglia tumours;
Revised classification of prognostic factors for many malignancies.
TNM Classification of Malignant Tumours is an essential resource for anyone involved in cancer care, research or cancer control.
TNM Atlas
a cura di
James D. Brierley
,
Hisao Asamura
Brian Rous
Elizabeth Van Eycken
e altri
editore: Wiley-Blackwell
pagine: 448
A fully illustrated guide to the current TNM classification (8th Edition) and staging system
The Union for International Cancer Control's (UICC) TNM classification system is the most widely used cancer classification and staging system in the world. It is used to describe the anatomical extent of disease and is, therefore, essential to patient care, research and cancer control.
This seventh edition of the TNM Atlas provides health-care professionals with a detailed pictorial guide to the system, demonstrating its practical application via clear, direct text and an array of full-color medical illustrations. The atlas features:
Specially produced content, created to reflect the most recent iteration of the TNM classification of malignant tumours, the 8th Edition
More than 300 full-color medical illustrations covering all anatomical sites of cancer involvement
Quick-reference material that is ideal for use in clinical and educational settings
The revised seventh edition of the TNM Atlas is a valuable resource for all medical, surgical, and radiation oncologists, anatomical and surgical pathologists, cancer registrars, oncology nurses, physician extenders, international cancer care centers and NGOs dedicated to cancer control.
